BDBM312188 6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-2H-benzo[b][1,4]oxazin-3(4H)-one::US10441590, Compound B::US9604944, 15b (Example 14)::US9975862, 15b (Example 14)
SMILES: Clc1cccc(N2CCN(CCCCOc3ccc4OCC(=O)Nc4c3)CC2)c1Cl
InChI Key: InChIKey=PMKMNTBZJOXTJW-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5-hydroxytryptamine receptor 2B (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 0.190 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Reviva Pharmaceuticals, Inc. US Patent | Assay Description Serotonin, 5HT1A: Materials and Methods:Receptor Source: Human recombinant 5-HT1A expressed mammalian cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)C... | US Patent US10441590 (2019) BindingDB Entry DOI: 10.7270/Q2959KXP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Dopamine D2 S receptor (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB UniProtKB/TrEMBL GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 0.610 | n/a | 1.96 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, INC. US Patent | Assay Description Receptor Source: Human recombinant expressed in CHO cells Radioligand: [3H]Spiperone (20-60 Ci/mmol) Control Compound: Haloperidol Incubatio... | US Patent US9604944 (2017) BindingDB Entry DOI: 10.7270/Q2ZW1NZ2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 0.610 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kochi Medical School | Assay Description Dopamine, D2S: Materials and Methods: Receptor Source: Human recombinant expressed in CHO cells Radioligand: [3H]Spiperone (20-60 Ci/mmol) C... | J Med Chem 52: 2226-32 (2009) BindingDB Entry DOI: 10.7270/Q2QZ2D9J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 0.620 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Reviva Pharmaceuticals, Inc. US Patent | Assay Description Dopamine, D2s: Radioligand: [3H]Spiperone (20-60 Ci/mmol) or [3H]-7-hydroxy DPAT, 1.0 nMControl Compound: Haloperidol or ChlorpromazineIncubation Con... | US Patent US10441590 (2019) BindingDB Entry DOI: 10.7270/Q2959KXP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.5 | n/a | 2.25 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, INC. US Patent | Assay Description Receptor Source: Human recombinant expressed in HEK-293 cells Radioligand: [3H]-8-OH-DPAT (221 Ci/mmol) Control Compound: 8-OH-DPAT Incubati... | US Patent US9604944 (2017) BindingDB Entry DOI: 10.7270/Q2ZW1NZ2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kochi Medical School | Assay Description Serotonin, 5HT1A:Receptor Source: Human recombinant expressed in HEK-293 cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)Control Compound: 8-OH-DPATInc... | J Med Chem 52: 2226-32 (2009) BindingDB Entry DOI: 10.7270/Q2QZ2D9J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Reviva Pharmaceuticals, Inc. US Patent | Assay Description Serotonin, 5HT1A: Materials and Methods:Receptor Source: Human recombinant 5-HT1A expressed mammalian cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)C... | US Patent US10441590 (2019) BindingDB Entry DOI: 10.7270/Q2959KXP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 2.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Reviva Pharmaceuticals, Inc. US Patent | Assay Description Serotonin, 5HT1A: Materials and Methods:Receptor Source: Human recombinant 5-HT1A expressed mammalian cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)C... | US Patent US10441590 (2019) BindingDB Entry DOI: 10.7270/Q2959KXP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 7 (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 2.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Reviva Pharmaceuticals, Inc. US Patent | Assay Description Serotonin, 5HT1A: Materials and Methods:Receptor Source: Human recombinant 5-HT1A expressed mammalian cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)C... | US Patent US10441590 (2019) BindingDB Entry DOI: 10.7270/Q2959KXP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 6 (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Reviva Pharmaceuticals, Inc. US Patent | Assay Description Serotonin, 5HT1A: Materials and Methods:Receptor Source: Human recombinant 5-HT1A expressed mammalian cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)C... | US Patent US10441590 (2019) BindingDB Entry DOI: 10.7270/Q2959KXP | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 58.5 | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
REVIVA PHARMACEUTICALS, INC. US Patent | Assay Description Receptor Source: Human Cortex Radioligand: [3H]-Ketanserin (60-90 Ci/mmol) Control Compound: Ketanserin Incubation Conditions: The reactions... | US Patent US9604944 (2017) BindingDB Entry DOI: 10.7270/Q2ZW1NZ2 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | 58.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Kochi Medical School | Assay Description Serotonin, 5HT2A :Materials and Methods: Receptor Source: Human Cortex Radioligand: [3H]-Ketanserin (60-90 Ci/mmol) Control Compound: Ketans... | J Med Chem 52: 2226-32 (2009) BindingDB Entry DOI: 10.7270/Q2QZ2D9J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 2A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Kochi Medical School | Assay Description Serotonin, 5HT2A :Materials and Methods: Receptor Source: Human Cortex Radioligand: [3H]-Ketanserin (60-90 Ci/mmol) Control Compound: Ketans... | J Med Chem 52: 2226-32 (2009) BindingDB Entry DOI: 10.7270/Q2QZ2D9J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5-hydroxytryptamine receptor 1A (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 2.25 | n/a | n/a | n/a | n/a | n/a | n/a |
Kochi Medical School | Assay Description Serotonin, 5HT1A:Receptor Source: Human recombinant expressed in HEK-293 cellsRadioligand: [3H]-8-OH-DPAT (221 Ci/mmol)Control Compound: 8-OH-DPATInc... | J Med Chem 52: 2226-32 (2009) BindingDB Entry DOI: 10.7270/Q2QZ2D9J | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
D(2) dopamine receptor (Homo sapiens (Human)) | BDBM312188 (6-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 1.96 | n/a | n/a | n/a | n/a | n/a | n/a |
Kochi Medical School | Assay Description Dopamine, D2S: Materials and Methods: Receptor Source: Human recombinant expressed in CHO cells Radioligand: [3H]Spiperone (20-60 Ci/mmol) C... | J Med Chem 52: 2226-32 (2009) BindingDB Entry DOI: 10.7270/Q2QZ2D9J | |||||||||||
More data for this Ligand-Target Pair |